News
Legislative/Advocacy
Speak Up in DC, Get Inspired at Medtrade
September 23, 2018
ATLANTA – My advocacy started when competitive bidding started. Two of my counties were included in round two of competitive bidding. When that first occurred, we all did not know what was going to happen. I went to DC and met with the late Senator
News
Legislative/Advocacy
Strong Grassroots Effort Needed to Ask House Members to Join Letter
September 22, 2018
Rep Cathy McMorris Rodgers (R-Wash) has released a Congressional sign-on letter to leadership at CMS, HHS, and OMB asking for additional relief for the HME community in the proposed ESRD/DMEPOS Rule currently under consideration. We are asking HME
News
Legislative/Advocacy
ESRD/DMEPOS Proposed Rule – Today is LAST DAY to Comment and Even a Brief Message Helps; “Let’s Take Full Advantage”
September 9, 2018
WASHINGTON, DC – The final version of the ESRD/DMEPOS Rule could have a tremendous impact on our industry for years to come, so it’s critical that we make our best case for improving CMS’ reimbursement policy now. For those of you who ha
News
Legislative/Advocacy
Make the Decision to Attend Medtrade
September 8, 2018
ATLANTA – It’s hard to believe we’re only weeks away from the annual voyage to Atlanta for Medtrade 2018. This will be my 21st Medtrade (16 with VGM), and each year the conference provides a platform for face-to-face discussion on today’
News
Legislative/Advocacy
GAO Report Asserts No Widespread Patient Access Issues
September 1, 2018
On Aug 24, the Government Accountability Office (GAO) released a report on the effects on reimbursement cuts in non-bid areas in the year following their implementation in January 2016. On their highlights page of the report, GAO asserts that their f
News
Legislative/Advocacy
GAO Finds Potential Organizational Conflict for QIC Contract Awardee
August 25, 2018
WASHINGTON, DC – Last month, the Government Accountability Office (GAO), the federal legislative branch’s research arm, announced that CMS failed to properly assess potential organizational conflict when they awarded MAXIMUS with the DMEPOS Q